Ana P. Lopes

Leflunomide–hydroxychloroquine combination therapy in patients with primary Sjögren's syndrome (RepurpSS-I): a placebo-controlled, double-blinded, randomised clinical trial

Eefje Hanna Martine van der Heijden, Sofie Liny Marie Blokland, Maarten R. Hillen et al. · The Lancet Rheumatology · 2020 · 91 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome

Lucas L. van den Hoogen, Joël A. G. van Roon, Jorre S. Mertens et al. · Annals of the Rheumatic Diseases · 2018 · 85 citations

Life Sciences, Immunology, Molecular Biology +17

CXCL4 drives fibrosis by promoting several key cellular and molecular processes

Alsya J. Affandi, Tiago Carvalheiro, Andrea Ottria et al. · Cell Reports · 2022 · 80 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum

Natália António, Rosa Fernandes, Ana da Rosa Soares et al. · Cardiovascular Diabetology · 2014 · 62 citations · Full text

Medicine, Cardiology, Endocrinology +16

Cytometry by time of flight identifies distinct signatures in patients with systemic sclerosis, systemic lupus erythematosus and Sjögrens syndrome

Maarten van der Kroef, Lucas L. van den Hoogen, Jorre S. Mertens et al. · European Journal of Immunology · 2019 · 61 citations · Full text

Medicine, Clinical Sciences, Immunology +17